Drug reference

quinupristin

Semisynthetic pristinamycin antibiotic · Antibacterial

Semisynthetic pristinamycin antibioticAntibacterial

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Quinupristin/Dalfopristin is a combination of two semisynthetic pristinamycin antibiotics which together exert synergistic inhibition of bacterial protein synthesis.

Indications

serious nosocomial MRSA infectionsVRE infectionsother resistant gram-positive infections

Related guidelines

Skin and soft tissue infections

IDSA · Infectious Diseases · 2010

Drug-resistant tuberculosis

RNTCP · Pulmonology · 2025

Acute dental pain and intraoral swelling

ADA_DENTAL · Dentistry · 2019

Infective endocarditis prevention

ADA_DENTAL · Dentistry · 2015

Urinary tract infection

EAU · Urology · 2024

Other Semisynthetic pristinamycin antibiotic drugs

dalfopristin

0 brands

Ask House about quinupristin

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team